PAVmed Inc. Equity Securities, FV-NI, Gain (Loss)
PAVmed Inc. (PAVM) reported Equity Securities, FV-NI, Gain (Loss) of $8.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-03-27
- PAVmed Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-12-31 was $2.50M, a 1903.20% increase year-over-year.
- PAVmed Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-09-30 was -$4.38M, a 1176.66% decline year-over-year.
- PAVmed Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-06-30 was -$10.64M.
- PAVmed Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-03-31 was $21.00M.
- PAVmed Inc. equity securities, fv-ni, gain (loss) for fiscal 2025 was $8.48M, a 1494.55% increase from fiscal 2024.
- PAVmed Inc. equity securities, fv-ni, gain (loss) for fiscal 2024 was $532.00K.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$1.88M derived: sum of 2 quarters · filed 2026-03-27 | -$12.52M derived: sum of 3 quarters · filed 2026-03-27 | $8.48M 10-K · filed 2026-03-27 |
| 2025-09-30 | -$4.38M 10-Q · filed 2025-11-12 | -$15.03M derived: sum of 2 quarters · filed 2025-11-12 | $5.98M 10-Q · filed 2025-11-12 | $6.10M derived: sum of 4 quarters · filed 2026-03-27 |
| 2025-06-30 | -$10.64M 10-Q · filed 2025-08-14 | $10.36M 10-Q · filed 2025-08-14 | $10.49M derived: sum of 3 quarters · filed 2026-03-27 | $10.89M derived: sum of 4 quarters · filed 2026-03-27 |
| 2025-03-31 | $21.00M 10-Q · filed 2025-05-15 | $21.13M derived: sum of 2 quarters · filed 2026-03-27 | $21.54M derived: sum of 3 quarters · filed 2026-03-27 | |
| 2024-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $532.00K derived: sum of 2 quarters · filed 2026-03-27 | $532.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $407.00K 10-Q · filed 2025-11-12 | $407.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |